Keywords: |
review; treatment planning; united states; human immunodeficiency virus infection; gastrointestinal symptom; vomiting; prevalence; risk factors; malaise; prophylaxis; benzodiazepine derivative; pregnancy; headache; antiretrovirus agent; virus load; anticonvulsive agent; proteinase inhibitor; oral contraceptive agent; anti-hiv agents; infection risk; hiv infections; disease transmission; zidovudine; lamivudine; lamivudine plus zidovudine; occupational exposure; nephrolithiasis; indinavir; stavudine; nelfinavir; seroconversion; needlestick injury; disease notification; didanosine; efavirenz; needlestick injuries; nevirapine; humans; human; female; disease transmission, patient-to-professional; pregnancy complications, infectious
|